Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $239.04, with a market capitalization of 33.06B. The stock trades at a price-to-earnings (P/E) ratio of -104.71.
On 2026-01-15, Natera(NTRA) stock traded between a low of $234.52 and a high of $243.03. Shares are currently priced at $239.04, which is +1.9% above the low and -1.6% below the high.
Natera(NTRA) shares are trading with a volume of 315.38K, against a daily average of 1.21M.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.
NTRA News
If you are wondering whether Natera's current share price lines up with its underlying value, you are not alone. This article is built to help you connect the d...
Natera Inc. (NTRA) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools...
Kallum Titchmarsh, an analyst from Morgan Stanley, maintained the Buy rating on Natera. The associated price target remains the same with $265.00. Claim 70% Off...
Analyst ratings
87%
of 23 ratingsMore NTRA News
Natera (NTRA) announced a new collaboration with NVIDIA (NVDA) to accelerate the development of Natera’s multimodal AI foundation model platform and expand appl...
Reports preliminary FY25 revenue $2.3B, consensus $2.22B. Approximately 923,600 tests were processed in the fourth quarter compared to 792,800 tests in the four...